The Fanconi anaemia/BRCA pathway

D'Andrea, Alan D., Grompe, Markus·2003·Nature Reviews Cancer
DOI 10.1038/nrc970

Cited by (823)

Items 101–200 of 823

  1. Pathology of hereditary breast cancer
    Petra van der Groep, Elsken van der Wall, P. J. van Diest · 2011 · Cellular Oncology
  2. Rediscovering the sweet spot in drug discovery
    David Brown, Giulio Superti‐Furga · 2003 · Drug Discovery Today
  3. Fanconi anemia pathway–deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated
    Richard D. Kennedy, Clark C. Chen, Patricia Stuckert, Elyse M. Archila, Michelle A. De la Vega, Lisa A. Moreau, Akiko Shimamura, Alan D. D’Andrea · 2007 · Journal of Clinical Investigation
  4. From syndrome families to functional genomics
    Han G. Brunner, Marc A. van Driel · 2004 · Nature Reviews Genetics
  5. DNA Repair Defects in Stem Cell Function and Aging
    Youngji Park, Stanton L. Gerson · 2004 · Annual Review of Medicine
  6. Somatic alterations in the human cancer genome
    Barbara A. Weir, Xiaojun Zhao, Matthew M. Meyerson · 2004 · Cancer Cell
  7. Fanconi anaemia and leukaemia – clinical and molecular aspects
    Marc D. Tischkowitz, Inderjeet S Dokal · 2004 · British Journal of Haematology
  8. Targeting the DNA repair defect of BRCA tumours
    Nicholas C. Turner, Andrew N.J. Tutt, Alan Ashworth · 2005 · Current Opinion in Pharmacology
  9. Cell cycle checkpoints and their impact on anticancer therapeutic strategies
    Alan R. Eastman · 2003 · Journal of Cellular Biochemistry
  10. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells
    Dauren S. Alimbetov, Sholpan Askarova, Bauyrzhan A. Umbayev, Terence Davis, David Kipling · 2018 · International Journal of Molecular Sciences
  11. Signaling Through Monoubiquitination
    Sara Sigismund, Simona Polo, Pier Paolo Di Fiore · 2004 · Current topics in microbiology and immunology
  12. Drugging the addict: non‐oncogene addiction as a target for cancer therapy
    Remco Nagel, Ekaterina A Semenova, Anton J. M. Berns · 2016 · EMBO Reports
  13. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway
    Jean Soulier, Thierry M Leblanc, Jérôme Larghero, Hélène Dastot, Akiko Shimamura, Philippe Guardiola, Hélène Espérou, Christèle Ferry, Charlotte Jubert, Jean‐Paul Feugeas et al. · 2004 · Blood
  14. Disruption of Murine Mus81 Increases Genomic Instability and DNA Damage Sensitivity but Does Not Promote Tumorigenesis
    Najoua Dendouga, Hui Jiang Gao, Dieder Moechars, Michel Janicot, Jorge E. Vialard, Clare H. McGowan · 2005 · Molecular and Cellular Biology
  15. Origin, Migration, and Proliferation of Human Primordial Germ Cells
    Massimo De Felici · 2012 · Springer eBooks
  16. Mutator genes for suppression of gross chromosomal rearrangements identified by a genome-wide screening in Saccharomyces cerevisiae
    Stephanie N. Smith, Ji‐Young Hwang, Soma Banerjee, Anju Majeed, Amitabha Gupta, Kyungjaem Myung · 2004 · Proceedings of the National Academy of Sciences
  17. Mechanisms leading to chromosomal instability
    Susanne M. Gollin · 2004 · Seminars in Cancer Biology
  18. The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells
    Qing Chen, Pieter Christiaan van der Sluis, David C. Boulware, Lori Hazlehurst, William S. Dalton · 2005 · Blood
  19. Emerging roles of BRCA1 alternative splicing
    Tamás István Orbán, Edith Oláh · 2003 · Molecular Pathology
  20. XPF-ERCC1 Participates in the Fanconi Anemia Pathway of Cross-Link Repair
    Nikhil R. Bhagwat, Anna L Olsen, Anderson T. Wang, Katsuhiro Hanada, Patricia Stuckert, Roland Kanaar, Alan D. D’Andrea, Laura J. Niedernhofer, Peter J. McHugh · 2009 · Molecular and Cellular Biology
  21. A FancD2-Monoubiquitin Fusion Reveals Hidden Functions of Fanconi Anemia Core Complex in DNA Repair
    Nobuko Matsushita, Hiroyuki Kitao, Masamichi Ishiai, Naoki Nagashima, Seiki Hirano, Katsuya Okawa, Tomohiko Ohta, David S. Yu, Peter J. McHugh, Ian David Hickson et al. · 2005 · Molecular Cell
  22. Precision oncology in the age of integrative genomics
    Chandan Kumar‐Sinha, Arul M. Chinnaiyan · 2018 · Nature Biotechnology
  23. Fanconi Anemia Protein FANCD2 Promotes Immunoglobulin Gene Conversion and DNA Repair through a Mechanism Related to Homologous Recombination
    Kazuhiko Yamamoto, Seiki Hirano, Masamichi Ishiai, Ken‐ichi Morishima, Hiroyuki Kitao, Keiko Namikoshi, Masayo Kimura, Nobuko Matsushita, Hiroshi Arakawa, Jean-Marie Buerstedde et al. · 2004 · Molecular and Cellular Biology
  24. BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation
    Shane Richard Stecklein, Easwari Kumaraswamy, Fariba Behbod, Wenjia Wang, Vamsee Chaguturu, Lisa M. Harlan-Williams, Roy A. Jensen · 2012 · Proceedings of the National Academy of Sciences
  25. Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells
    Jacinth Abraham, Bénédicte Lemmers, Manoor Prakash Hande, Mary Ellen Moynahan, Charly Chahwan, Alberto Ciccia, Jeroen Essers, Katsuhiro Hanada, Richard Chahwan, Aik Kia Khaw et al. · 2003 · The EMBO Journal
  26. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin
    Rocio Montes De Oca, Paul R. Andreassen, Steven P. Margossian, Richard C. Gregory, Toshiyasu Taniguchi, XiaoZhe Wang, Scott Robert Houghtaling, Markus Grompe, Alan D. D’Andrea · 2004 · Blood
  27. A Unique Subset of Epithelial Ovarian Cancers with Platinum Sensitivity and PARP Inhibitor Resistance
    Raphaël Ceccaldi, Kevin W. O’Connor, Kent William Mouw, Adam Y. Li, Ursula A. Matulonis, Alan D. D’Andrea, Panagiotis A. Konstantinopoulos · 2015 · Cancer Research
  28. Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions
    Spyridon P. Basourakos, Likun Li, Ana M. Aparicio, Paul Gettys Corn, Jeri Kim, Timothy C. Thompson · 2016 · Current Medicinal Chemistry
  29. BRCA1-independent ubiquitination of FANCD2
    Vandenberg, Cassandra J., Gergely, Fanni, Ong, Chong Yi, Pace, Paul, Mallery, Donna L., Hiom, Kevin, Patel, Ketan J. · 2003 · Molecular Cell
  30. The FANCM/FAAP24 Complex Is Required for the DNA Interstrand Crosslink-Induced Checkpoint Response
    Min Huang, Jung Min ‍Kim, Bunsyo Shiotani, Kailin Yang, Lee Zou, Alan D. D’Andrea · 2010 · Molecular Cell
  31. Formaldehyde and leukemia: Epidemiology, potential mechanisms, and implications for risk assessment
    Luoping Zhang, Laura E. Beane Freeman, Jun Nakamura, Stephen S. Hecht, John J. Vandenberg, Martyn T. Smith, Babasaheb R. Sonawane · 2009 · Environmental and Molecular Mutagenesis
  32. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability
    Massimo Bogliolo, Alex Lyakhovich, Elsa Callén, María Castellà, Enrico Cappelli, Marı́a José Ramı́rez, Amadeu Creus, Ricard Marcos, Reinhard Kalb, Kornelia Neveling et al. · 2007 · The EMBO Journal
  33. Who's on first in the cellular response to DNA damage?
    Cline, Susan D., Hanawalt, Philip C. · 2003 · Nature Reviews Molecular Cell Biology
  34. Oxidative Stress in Fanconi Anemia Hematopoiesis and Disease Progression
    Wei Du, Zsuzsanna Ádám, Reena Rani, Xiaoling Zhang, Qishen Pang · 2008 · Antioxidants and Redox Signaling
  35. Functional Defects in the Fanconi Anemia Pathway in Pancreatic Cancer Cells
    Michiel S. van der Heijden, Jonathan Robert Brody, Eike Gallmeier, Steven Clark Cunningham, David A. Dezentjé, Dong Shen, Ralph H. Hruban, Scott E. Kern · 2004 · American Journal Of Pathology
  36. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM
    Seiki Hirano, Kazuhiko Yamamoto, Masamichi Ishiai, Mitsuyoshi Yamazoe, Masayuki Seki, Nobuko Matsushita, Mioko Ohzeki, Yukiko M Yamashita, Hiroshi Arakawa, Jean-Marie Buerstedde et al. · 2004 · The EMBO Journal
  37. BRCA1/BRCA2Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
    Anbok Lee, Byung-In Moon, Tae Hyun Kim · 2019 · Annals of Laboratory Medicine
  38. Rad51 siRNA delivered by HVJ envelope vector enhances the anti‐cancer effect of cisplatin
    Makoto Ito, Seiji Yamamoto, Keisuke Nimura, Kazuya Hiraoka, Katsuto Tamai, Yasufumi Kaneda · 2005 · The Journal of Gene Medicine
  39. The mammalian XRCC genes: their roles in DNA repair and genetic stability
    John Thacker, Małgorzata Z. Zdzienicka · 2003 · DNA repair
  40. Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
    Yoshimoto, Koji, Mizoguchi, Masahiro, Hata, Nobuhiro, Murata, Hideki, Hatae, Ryusuke, Amano, Toshiyuki, Nakamizo, Akira, Sasaki, Tomio · 2012 · Frontiers in Oncology
  41. Common Variants in Immune and DNA Repair Genes and Risk for Human Papillomavirus Persistence and Progression to Cervical Cancer
    Sophia Wang, M. Concepción Bratti, Ana Cecilia Rodríguez, Rolando Herrero, Robert D. Burk, Carolina Porras, Paula González, Mark E. Sherman, Sholom Wacholder, Z. Elizabeth Lan et al. · 2008 · The Journal of Infectious Diseases
  42. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation
    Caroline Masserot, Régis Peffault de Latour, Vanderson Rocha, Thierry M Leblanc, Arnaud Rigolet, Francis Pascal, Anne Janin, Jean Soulier, Éliane Gluckman, Gèrard Socié · 2008 · Cancer
  43. Clinical implications of molecular heterogeneity in triple negative breast cancer
    Brian David Lehmann, Jennifer A. Pietenpol · 2015 · The Breast
  44. Therapy‐related myeloid neoplasms: pathobiology and clinical characteristics
    Heinz Sill, Werner Olipitz, Armin Zebisch, Eduard Schulz, Albert Wölfler · 2010 · British Journal of Pharmacology
  45. BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks
    Pietro Pichierri, Annapaola Franchitto, Filippo Rosselli · 2004 · The EMBO Journal
  46. Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour
    Sarah Reid, A Renwick, S Seal, L Baskcomb, R Barfoot, H Jayatilake, Kathy Pritchard‐Jones, M R Stratton, A Ridolfi-Lüthy, N Rahman · 2005 · Journal of Medical Genetics
  47. Identification of Target Genes of the p16INK4A-pRB-E2F Pathway
    Richard Vernell, Kristian Helin, Heiko Müller · 2003 · Journal of Biological Chemistry
  48. Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication
    Stephen K. Godin, Meghan R. Sullivan, Kara Anne Bernstein · 2016 · Biochemistry and Cell Biology
  49. Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance
    Gary P. H. Ho, Steven P. Margossian, Toshiyasu Taniguchi, Alan D. D’Andrea · 2006 · Molecular and Cellular Biology
  50. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1
    Shobbir Hussain · 2003 · Human Molecular Genetics
  51. Systemic DNA damage responses in aging and diseases
    Ribezzo, Flavia, Shiloh, Yosef, Schumacher, Björn · 2016 · Seminars in Cancer Biology
  52. DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells
    Katrin Kemp Gudmundsdottir, Christopher J. Lord, Emily Witt, Andrew N.J. Tutt, Alan Ashworth · 2004 · EMBO Reports
  53. Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1
    Parmar, Kalindi, Kim, Jungmin, Sykes, Stephen M., Shimamura, Akiko, Stuckert, Patricia, Zhu, Kaya, Hamilton, Abigail, Deloach, Mary Kathryn, Kutok, Jeffery L., Akashi, Koichi et al. · 2010 · Stem Cells
  54. Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms
    Eduard Schulz, Angelika Valentin, Peter Ulz, Christine Beham‐Schmid, KARIN LIND, Verena Rupp, Herwig Lackner, Albert Wölfler, Armin Zebisch, Werner Olipitz et al. · 2012 · Journal of Medical Genetics
  55. Knockdown of Zebrafish Fancd2 Causes Developmental Abnormalities via p53-Dependent Apoptosis
    Ting Xi Liu, Niall G. Howlett, Min Deng, David M. Langenau, Karl Hsu, Jennifer Rhodes, John P. Kanki, Alan D. D’Andrea, Alfred Thomas Look · 2003 · Developmental Cell
  56. Hsp90: A New Player in DNA Repair?
    Pennisi, Rosa, Ascenzi, Paolo, Di Masi, Alessandra · 2015 · Biomolecules
  57. Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1
    Cantor, Sharon B, Guillemette, Shawna · 2011 · Future Oncology
  58. Large-scale RNA-Seq Transcriptome Analysis of 4043 Cancers and 548 Normal Tissue Controls across 12 TCGA Cancer Types
    Li Jen Peng, Xiu Wu Bian, Di Kang Li, Chuan Shan Xu, Guangming Wang, Qing You Xia, Qing Xiong · 2015 · Scientific Reports
  59. Viral Perturbations of Host Networks Reflect Disease Etiology
    Natali Gulbahce, Han Yan, Amélie Dricot, Megha Padi, Danielle Byrdsong, Rachel Franchi, Deok‐Sun Lee, Orit Rozenblatt–Rosen, Jessica C. Mar, Michael A. Calderwood et al. · 2012 · PLoS Computational Biology
  60. Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2
    Lindsey E. Minion, Jill S. Dolinsky, Dana M. Chase, Charles L.M. Dunlop, Elizabeth Chao, Bradley J. Monk · 2015 · Gynecologic Oncology
  61. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome
    Philippe Guardiola, Gèrard Socié, Xiaxin Li, Patricia Ribaud, A Devergié, Hélène Espérou, Patrice Richard, Richard Traineau, Anne Janin, Éliane Gluckman · 2003 · Blood
  62. Influence of double-strand-break repair pathways on radiosensitivity throughout the cell cycle in CHO cells
    John M. Hinz, Nazumi Alice Yamada, Edmund P. Salazar, Robert S. Tebbs, Larry H. Thompson · 2005 · DNA repair
  63. Role of human Pso4 in mammalian DNA repair and association with terminal deoxynucleotidyl transferase
    Kiran N. Mahajan, Beverly S. Mitchell · 2003 · Proceedings of the National Academy of Sciences
  64. Minding the gap: The underground functions of BRCA1 and BRCA2 at stalled replication forks
    Ganesh Nagaraju, Ralph Scully · 2007 · DNA repair
  65. How Fanconi anemia proteins promote the four Rs: Replication, recombination, repair, and recovery
    Larry H. Thompson, John M. Hinz, Nazumi Alice Yamada, Nigel J. Jones · 2005 · Environmental and Molecular Mutagenesis
  66. Histopathology of BRCA1- and BRCA2-associated breast cancer
    Emiliano Honrado, Javier J. Benitez, José Palacios · 2006 · Critical Reviews in Oncology/Hematology
  67. FANCL Replaces BRCA1 as the Likely Ubiquitin Ligase Responsible for FANCD2 Monoubiquitination
    Amom Ruhikanta Meetei, Zhijiang Yan, Weidong Wang · 2004 · Cell Cycle
  68. Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors
    Iacopo Petrini, Paul S. Meltzer, Paolo Andrea Zucali, Ji Luo, Chyi‐Chia Richard Lee, Armando Santoro, Hye Seung Lee, Keith J. Killian, Y. Wang, Maria Tsokos et al. · 2012 · Cell Death and Disease
  69. Genomic instability and cancer: Networks involved in response to DNA damage
    Jorunn Erla Eyfjord, Sigríður Klara Böðvarsdóttir · 2005 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  70. The Fanconi road to cancer: Figure 1.
    Alan D. D’Andrea · 2003 · Genes & Development
  71. Pathways of DNA double-strand break repair and their impact on the prevention and formation of chromosomal aberrations
    Petra Pfeiffer, Wolfgang Goedecke, Steffi Kuhfittig-Kulle, G�nter Obe · 2004 · Cytogenetic and Genome Research
  72. PARP Inhibitors and Prostate Cancer: To Infinity and BeyondBRCA
    Emily N. Risdon, Cindy H. Chau, Douglas K. Price, Oliver A. Sartor, William Douglas Figg · 2020 · The Oncologist
  73. Oxidative Stress and the Myelodysplastic Syndromes
    Morag J. Farquhar, David Bowen · 2003 · International Journal of Hematology
  74. Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer
    Christina M. Annunziata, Joyce O’Shaughnessy · 2010 · Clinical Cancer Research
  75. DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates
    Jennifer L. Illuzzi, Sarah Yerkes, Hetal Parekh‐Olmedo, Eric Brian Kmiec · 2008 · Journal of Neuroscience Research
  76. Individualized risks of first adverse events in patients with Fanconi anemia
    Philip S. Rosenberg, Yi Huang, Blanche P. Alter · 2004 · Blood
  77. The Molecular Pathology of Hereditary Breast Cancer
    José Palacios, María José Robles‐Frías, María Ángeles Castilla, M. Ángeles López‐García, Javier J. Benitez · 2008 · Pathobiology
  78. Fanconi Anemia Proteins Are Required To Prevent Accumulation of Replication-Associated DNA Double-Strand Breaks
    Alexandra Sobeck, Stacie Stone, Vincenzo Costanzo, Bendert de Graaf, Tanja Reuter, Johan P. de Winter, Michael Wallisch, Yassmine M. N. Akkari, Susan B. Olson, Weidong Wang et al. · 2005 · Molecular and Cellular Biology
  79. Nonequivalent Gene Expression and Copy Number Alterations in High-Grade Serous Ovarian Cancers with BRCA1 and BRCA2 Mutations
    Joshy George, Kathryn Alsop, Dariush Etemadmoghadam, Heather Hondow, Thomas Mikeska, Alexander Dobrovic, Anna DeFazio, Georgia Chenevix‐Trench, Gordon K. Smyth, Douglas A. Levine et al. · 2013 · Clinical Cancer Research
  80. Focus on myeloproliferative diseases and myelodysplastic syndromes
    Richard A. Van Etten, Kevin Shannon · 2004 · Cancer Cell
  81. The Rb tumor suppressor is required for stress erythropoiesis
    Benjamin T. Spike, Alexandra Dirlam, Benjamin C. Dibling, James Marvin, Bart O. Williams, Tyler Jacks, Kay F. Macleod · 2004 · The EMBO Journal
  82. The role of DNA repair in the pluripotency and differentiation of human stem cells
    Clarissa Ribeiro Reily Rocha, Letícia Koch Lerner, Oswaldo Keith Okamoto, Maria Carolina Marchetto, Carlos Frederico Martins Menck · 2012 · Mutation Research/Reviews in Mutation Research
  83. Natural gene therapy in monozygotic twins with Fanconi anemia
    Anuj Mankad, Toshiyasu Taniguchi, Barbara Cox, Yassmine M. N. Akkari, R. Keaney Rathbun, Lora Lucas, Grover C. Bagby, Susan B. Olson, Alan D. D’Andrea, Markus Grompe · 2006 · Blood
  84. Deubiquitylating Enzymes and DNA Damage Response Pathways
    Xavier Jacq, Mark I. Kemp, Niall M.B. Martin, Stephen P. Jackson · 2013 · Cell Biochemistry and Biophysics
  85. Werner Syndrome Helicase Has a Critical Role in DNA Damage Responses in the Absence of a Functional Fanconi Anemia Pathway
    Monika Aggarwal, Taraswi Banerjee, Joshua A. Sommers, Chiara Iannascoli, Pietro Pichierri, Robert H. Shoemaker, Robert M. Brosh · 2013 · Cancer Research
  86. Aldehydes with high and low toxicities inactivate cells by damaging distinct cellular targets
    Ming-Zhang Xie, Mahmoud I. Shoulkamy, Amir M.H. Salem, Shunya Oba, Mizuki Goda, Toshiaki Nakano, Hiroshi Ide · 2016 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  87. RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair
    Jingxin Wang, Naduparambil Korah Jacob, Katherine J. Ladner, Amer A. Beg, James D. Perko, Stephan M. Tanner, Sandya Liyanarachchi, Richard A. Fishel, Denis C. Guttridge · 2009 · EMBO Reports
  88. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property
    Prasad, Chandra Bhushan, Prasad, Shyam Babu, Yadav, Suresh Singh, Pandey, Laxmi Kant, Singh, Sunita, Pradhan, Satyajit, Narayan, Gopeshwar · 2017 · Scientific Reports
  89. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly
    Kanchan D. Mirchandani, Ryan M. McCaffrey, Alan D. D’Andrea · 2008 · DNA repair
  90. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway
    Nianxiang Zhang, Xiuping Liu, Lei Li, Randy J. Legerski · 2007 · DNA repair
  91. Estrogen receptor α, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers
    Minjie Wei, Jinhua Xu, James J. Dignam, Rita Nanda, Lise Sveen, James D. Fackenthal, Tatyana A. Grushko, Olufunmilayo Ibironke Olopade · 2007 · Breast Cancer Research and Treatment
  92. Current challenges of metastatic breast cancer
    Bora Lim, Gabriel N. Hortobágyi · 2016 · Cancer and Metastasis Reviews
  93. Efficient embryonic homozygous gene conversion via RAD51-enhanced interhomolog repair
    Jonathan J. Wilde, Tomomi Aida, Ricardo C.H. del Rosario, Tobias Kaiser, Peimin Qi, Martin Wienisch, Qiangge Zhang, Steven M. Colvin, Guoping Feng · 2021 · Cell
  94. The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI
    Stacy A. Williams, Simonne Longerich, Patrick Sung, Cyrus Vaziri, Gary M. Kupfer · 2011 · Blood
  95. Human SNM1B is required for normal cellular response to both DNA interstrand crosslink-inducing agents and ionizing radiation
    Ilja Demuth, Martin Digweed, PATRICK J. CONCANNON · 2004 · Oncogene
  96. Identification of Tissue microRNAs Predictive of Sunitinib Activity in Patients with Metastatic Renal Cell Carcinoma
    Celia Prior, José Luis Perez‐Gracia, Jesús García-Donás, Cristina Rodríguez‐Antona, Elizabeth Guruceaga, Emilio Esteban, Cristina Suárez, Daniel Castellano, Aranzazu González del Alba, María D. Lozano et al. · 2014 · PLoS ONE
  97. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy
    Khaleel R Fareed, Ahmad Al‐Attar, Irshad Nabi Soomro, Philip Kaye, J Patel, Dileep N. Lobo, Simon L. Parsons, Srinivasan Madhusudan · 2010 · British Journal of Cancer
  98. RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection
    Richard Lynn Bennett, William L. Blalock, Dean Abtahi, Yu Pan, Sue A. Moyer, William Stratford May · 2006 · Blood
  99. Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage.
    Asmin Tulpule, M. Lensch, Justine D. Miller, Karyn M. Austin, A. D'Andrea, T. Schlaeger, A. Shimamura, George Q. Daley · 2010 · Blood
  100. DNA Cross-Link Repair Protein SNM1A Interacts with PIAS1 in Nuclear Focus Formation
    Masamichi Ishiai, Masayo Kimura, Keiko Namikoshi, Mitsuyoshi Yamazoe, Kazuhiko Yamamoto, Hiroshi Arakawa, Kazunaga Agematsu, Nobuko Matsushita, Shunichi Takeda, Jean-Marie Buerstedde et al. · 2004 · Molecular and Cellular Biology